Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells

Ghizlane Maarifi (1) , Justine Lagisquet (1) , Quentin Hertel (1) , Boris Bonaventure (1) , Célia Chamontin (1) , Kyra Fuchs (1) , Olivier Moncorgé (1) , Marine Tauziet (1) , Margaux Mombled (1) , Laure Papin (1) , Jean‐pierre Molès (2) , Charles Bodet (3) , Nicolas Lévèque (3) , Antoine Gross (1) , Nathalie J Arhel (1) , Sébastien Nisole (1) , Philippe van de Perre (2, 4) , Caroline Goujon (1) , Fabien P. Blanchet (1)

1 IRIM - Institut de Recherche en Infectiologie de Montpellier
2 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
3 LITEC [Poitiers] - Laboratoire Inflammation, Tissus épithéliaux et Cytokines [EA 4331]
4 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]

Domaines: Sciences du Vivant [q-bio]

Ghizlane Maarifi, Justine Lagisquet, Quentin Hertel, Boris Bonaventure, Célia Chamontin, et al.. Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells. EMBO Journal, 2021, 40 (16), ⟨10.15252/embj.2020106540⟩. ⟨hal-03375823⟩